ArticleInternational journal of clinical oncology2024

PMDA regulatory update on approval of new drugs and revisions of precautions; approval of talazoparib tosilate for prostate and breast cancer, and luspatercept for myelodysplastic syndrome in Japan.

Noriomi Matsumura et al.PubMed ↗Publisher ↗

No numbers read from the abstract.